Anti-tumor necrosis factor treatment in ankylosing spondylitis may not relate to poor prognosis in COVID-19

Lignende værker

• Adverse events of anti-tumor necrosis factor α therapy in ankylosing spondylitis.
  af: Qiang Tong, et al.
  Udgivet: (2015-01-01)
• Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
  af: Tong, Qiang, et al.
  Udgivet: (2015)
• Predictors of Switching Anti-Tumor Necrosis Factor Therapy in Patients with Ankylosing Spondylitis
  af: Lee, Jeong-Won, et al.
  Udgivet: (2015)
• Correction: Adverse Events of Anti-Tumor Necrosis Factor α Therapy in Ankylosing Spondylitis
  af: Tong, Qiang, et al.
  Udgivet: (2015)
• Targeting tumor necrosis factor receptors in ankylosing spondylitis
  af: Lata, Michal, et al.
  Udgivet: (2018)